MTXX: Matrixx Initiatives Inc - Full Company Report
Enter Ticker:
Matrixx Initiatives, Inc. is an innovative nutrient and drug delivery technology company engaged in the development, manufacture and marketing of delivery systems for bioactive compounds. Gel Tech, LLC, its wholly-owned subsidiary, produces, markets and sells Zicam Cold Remedy nasal gel, a patented, homeopathic remedy that significantly reduces the duration and severity of the common cold, and Zicam Allergy Relief nasal gel, a homeopathic remedy designed to provide relief to allergy sufferers.
General Information
MATRIXX INITITV
8515 E. Anderson Drivewww.matrixxinc.com lromero@matrixxinc.com
Industry
MED-DRUGS
Sector:
Medical
Fiscal Year End
March
Last Reported Quarter
09/30/09
Next EPS Date
01/25/2010
Price and Volume Information
Zacks Rank
Yesterday's Close
4.11
52 Week High
19.74
52 Week Low
3.61
Beta
0.39
20 Day Moving Average
563,293.25
Target Price Consensus
5
% Price Change
4 Week
-16.10
12 Week
-20.38
YTD
-74.41
% Price Change Relative to S&P 500
4 Week
-17.01
12 Week
-24.93
YTD
-78.82
Share Information
Shares Outstanding (millions)
9.46
Market Capitalization (millions)
39.90
Short Ratio
4.01
Last Split Date
N/A
Dividend Information
Dividend Yield
0.00%
Annual Dividend
$0.00
Payout Ratio
0.00
Change in Payout Ratio
0.00
Last Dividend Payout / Amount
NA / $0.00
EPS Information
Current Quarter EPS Consensus Estimate
0.09
Current Year EPS Consensus Estimate
-1.26
Estimated Long-Term EPS Growth Rate
-
Next EPS Report Date
01/25/2010
Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)
3.00
30 Days Ago
3.00
60 Days Ago
3.00
90 Days Ago
3.00
Fundamental Ratios
P/E
Current FY Estimate:
-
Trailing 12 Months:
8.79
PEG Ratio
-
EPS Growth
vs. Previous Year
-35.29%
vs. Previous Quarter
161.11%
Sales Growth
vs. Previous Year
-23.80%
vs. Previous Quarter:
270.55%
Price Ratios
Price/Book
0.70
Price/Cash Flow
2.61
Price / Sales
0.39
ROE
09/30/09
7.46
06/30/09
11.84
03/31/09
21.44
ROA
09/30/09
5.76
06/30/09
9.14
03/31/09
17.14
Current Ratio
09/30/09
4.11
06/30/09
3.05
03/31/09
4.37
Quick Ratio
09/30/09
3.78
06/30/09
2.74
03/31/09
3.87
Operating Margin
09/30/09
4.64
06/30/09
7.18
03/31/09
13.31
Net Margin
09/30/09
-15.63
06/30/09
-9.87
03/31/09
20.25
Pre-Tax Margin
09/30/09
-15.63
06/30/09
-9.87
03/31/09
20.25
Book Value
09/30/09
6.03
06/30/09
5.45
03/31/09
7.73
Inventory Turnover
09/30/09
3.87
06/30/09
3.52
03/31/09
3.04
Debt-to-Equity
09/30/09
0.00
06/30/09
0.00
03/31/09
0.00
Debt to Capital
09/30/09
0.00
06/30/09
0.00
03/31/09
0.00
Sponsored Links 
0.04